Results 31 to 40 of about 342 (178)

Mastocitosis Cutánea: Revisión y actualización [PDF]

open access: yes
Realizar una revisión bibliográfica sobre Mastocitosis cutánea, sintetizando la información de las diferentes formas de manifestación, su clínica, diagnóstico, tratamiento y pronóstico, así como del estado actual de la investigación acerca de nuevos ...
Alcaine González, Clara   +1 more
core   +2 more sources

Histiocitosis cefálica benigna simulando una mastocitosis

open access: yesActas Dermo-Sifiliográficas, 2022
E. Silva Díaz   +3 more
doaj   +2 more sources

High burden of clonal mast cell disorders and hereditary α-tryptasemia in patients who need Hymenoptera venom immunotherapy. [PDF]

open access: yesAllergy
In this multicenter study, we have demonstrated that clonal mast cell disease and HαT are more prevalent among individuals who need VIT; one or both was found in 27% of individuals overall. Both diagnoses were highly concentrated among individuals with severe anaphylaxis.
Korošec P   +24 more
europepmc   +2 more sources

Mastocitosis sistémica con afectación de piel versus mastocitosis indolente [PDF]

open access: yesAnales de Medicina Interna, 2001
El objetivo de trabajo es la presentación de los datos clínicos, analíticos, radiológicos, terapéuticos y de evolución de un caso de matocitosis sistémica (MS) con afectación de piel. Revisando la literatura ya que la mastocitosis sigue siendo una enfermedad de difídicl diagnóstico, sobre todo en los casos que no existen alteraciones cutáneas.
Tiberio,G.   +5 more
openaire   +4 more sources

A case of high‐risk AML in a patient with advanced systemic mastocytosis

open access: yesClinical Case Reports, Volume 11, Issue 7, July 2023., 2023
Abstract Aggressive SM + AML has limited therapeutic options. Even a strong combination of decitabine–venetoclax–midostaurin has a transient effect on AML and a mitigated effect on SM. Larger series are required to identify the best therapeutic strategy.
Manlio Fazio   +15 more
wiley   +1 more source

Artificial intelligence processing electronic health records to identify commonalities and comorbidities cluster at Immuno Center Humanitas

open access: yesClinical and Translational Allergy, Volume 12, Issue 6, June 2022., 2022
Abstract Background Comorbidities are common in chronic inflammatory conditions, requiring multidisciplinary treatment approach. Understanding the link between a single disease and its comorbidities is important for appropriate treatment and management.
Pierandrea Morandini   +10 more
wiley   +1 more source

Flow cytometry of duodenal intraepithelial lymphocytes improves diagnosis of celiac disease in difficult cases. [PDF]

open access: yesUnited European Gastroenterol J, 2017
Background Diagnosis of celiac disease is difficult when the combined results of serology and histology are inconclusive. Studies using flow cytometry of intraepithelial lymphocytes (IELs) have found that celiac patients have increased numbers of γδ IELs, along with a decrease in CD3‐CD103 + IELs.
Valle J   +7 more
europepmc   +2 more sources

Mastocitosis sistémicas

open access: yes, 2006
Christopher Chang
core   +2 more sources

CUTANEOUS MASTOCYTOSIS IN THE ADULT: WHAT LIES BENEATH

open access: yesGalicia Clínica, 2020
Mastocytosis is a disorder characterized by clonal mast cell proliferation and accumulation within various organs, most commonly, the skin. Adult-onset mastocytosis is highly suggestive of a systemic involvement and the cases limited to the skin are ...
Liliana Torres   +3 more
doaj   +1 more source

Mast cell activation syndrome. About a clinical case

open access: yesRevista Alergia México, 2019
Background: Monoclonal mast cell activation syndrome is included in mast cell activation disorders in which, after a diagnostic process, it is not possible to meet the required criteria for a diagnosis of systemic mastocytosis.
Ricardo Cardona   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy